The draining lymph node in rheumatoid arthritis: Current concepts and research perspectives

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Benaglio, Francesca ^a   Vitolo, Barbara ^a   Scarabelli, Martina ^a   Binda, Elisa ^a   Bugatti, Serena ^a   Caporali, Roberto ^a   Montecucco, Carlomaurizio ^a   Manzo, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL MIGRATION; CHRONIC ARTHRITIS; DENDRITIC CELL; DISEASE ACTIVITY; FLOW CYTOMETRY; FOLLICULAR DENDRITIC CELL; HOMEOSTASIS; HUMAN; IMMUNE FUNCTION TEST; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; INFLAMMATION; LUNG; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE; LYMPHOCYTE RECIRCULATION; LYMPHOID TISSUE; MEMORY CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; PATHOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; LYMPH NODES;

EID: 84924587849     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/420251     Document Type: Review

References (178)

1. P. Höglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis, "Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes," Journal of Experimental Medicine, Vol. 189, no. 2, pp. 331-339, 1999.
2. M. C. Gagnerault, J. J. Luan, C. Lotton, and F. Lepault, "Pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice," Journal of Experimental Medicine, Vol. 196, no. 3, pp. 369-377, 2002.
3. H. Kim, R. P. Kataru, and G. Y. Koh, "Inflammation-associated lymphangiogenesis: a double-edged sword?" The Journal of Clinical Investigation, Vol. 124, no. 3, pp. 936-942, 2014.
4. L. C. Dieterich, C. D. Seidel, and M. Detmar, "Lymphatic vessels: new targets for the treatment of inflammatory diseases," Angiogenesis, Vol. 17, no. 2, pp. 359-371, 2014.
5. K. W. Tan, S. Z. Chong, and V. Angeli, "Inflammatory lymphangiogenesis: cellular mediators and functional implications," Angiogenesis, Vol. 17, no. 2, pp. 373-381, 2014.
6. P. Baluk, T. Tammela, E. Ator et al., "Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation," The Journal of Clinical Investigation, Vol. 115, no. 2, pp. 247-257, 2005.
7. R. Huggenberger, S. Ullmann, S. T. Proulx, B. Pytowski, K. Alitalo, and M. Detmar, "Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation," Journal of Experimental Medicine, Vol. 207, no. 10, pp. 2255-2269, 2010.
8. R. Huggenberger, S. S. Siddiqui, D. Brander et al., "An important role of lymphatic vessel activation in limiting acute inflammation," Blood, Vol. 117, no. 17, pp. 4667-4678, 2011.
9. C. A. Hitchon and H. S. El-Gabalawy, "The synovium in rheumatoid arthritis," Open Rheumatology Journal, Vol. 5, no. 1, pp. 107-114, 2011.
10. A. Manzo, M. Bombardieri, F. Humby, and C. Pitzalis, "Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling," Immunological Reviews, Vol. 233, no. 1, pp. 267-285, 2010.
11. G. Schett and E. Gravallese, "Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment," Nature Reviews Rheumatology, Vol. 8, no. 11, pp. 656-664, 2012.
12. C. Pitzalis, S. Kelly, and F. Humby, "New learnings on the patho-physiology of RA from synovial biopsies," Current Opinion in Rheumatology, Vol. 25, no. 3, pp. 334-344, 2013.
13. S. Bugatti, A. Manzo, M. Bombardieri et al., "Synovial tissue heterogeneity and peripheral blood biomarkers," Current Rheumatology Reports, Vol. 13, no. 5, pp. 440-448, 2011.
14. S. Bugatti, A. Manzo, R. Caporali, and C. Montecucco, "Assessment of synovitis to predict bone erosions in rheumatoid arthritis," Therapeutic Advances in Musculoskeletal Disease, Vol. 4, no. 4, pp. 235-244, 2012.
15. S. Rantapää-Dahlqvist, B. A. W. de Jong, E. Berglin et al., "Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis," Arthritis and Rheumatism, Vol. 48, no. 10, pp. 2741-2749, 2003.
16. M. M. J. Nielen, D. van Schaardenburg, H. W. Reesink et al., "Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors," Arthritis and Rheumatism, Vol. 50, no. 2, pp. 380-386, 2004.
17. M. G. H. van de Sande, M. J. H. de Hair, C. van der Leij et al., "Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase," Annals of the Rheumatic Diseases, Vol. 70, no. 5, pp. 772-777, 2011.
18. Y. Y. J. Gent, A. E. Voskuyl, R. W. Kloet et al., "Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study," Arthritis and Rheumatism, Vol. 64, no. 1, pp. 62-66, 2012.
19. A. Krabben, W. Stomp, D. M. F. M. van der Heijde et al., "MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 9, pp. 1540-1544, 2013.
20. M. J. H. de Hair, M. G. H. van de Sande, T. H. Ramwadhdoebe et al., "Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis," Arthritis and Rheumatology, Vol. 66, no. 3, pp. 513-522, 2014.
21. G. Reynisdottir, R. Karimi, V. Joshua et al., "Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis," Arthritis and Rheumatology, Vol. 66, no. 1, pp. 31-39, 2014.
22. J. U. Scher, C. Ubeda, M. Equinda et al., "Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis," Arthritis and Rheumatism, Vol. 64, no. 10, pp. 3083-3094, 2012.
23. T. R. Mikuls, G. M. Thiele, K. D. Deane et al., "Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis," Arthritis and Rheumatism, Vol. 64, no. 11, pp. 3522-3530, 2012.
24. S. B. Brusca, S. B. Abramson, and J. U. Scher, "Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity," Current Opinion in Rheumatology, Vol. 26, no. 1, pp. 101-107, 2014.
25. S. Bugatti, R. Caporali, A. Manzo, G. Sakellariou, S. Rossi, and C. Montecucco, "Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis," Annals of the Rheumatic Diseases, Vol. 71, no. 4, pp. 625-626, 2012.
26. A. Krabben, W. Stomp, D. M. F. M. van der Heijde et al., "MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 9, pp. 1540-1544, 2013.
27. F. M. McQueen, "Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective," Arthritis Research and Therapy, Vol. 14, no. 5, article 224, 2012.
28. S. Bugatti, A. Manzo, R. Caporali, and C. Montecucco, "Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective," Arthritis Research and Therapy, Vol. 14, no. 6, p. 229, 2012.
29. C. L. Willard-Mack, "Normal structure, function, and histology of lymph nodes," Toxicologic Pathology, Vol. 34, no. 5, pp. 409-424, 2006.
30. U. H. von Andrian and T. R. Mempel, "Homing and cellular trafic in lymph nodes," Nature Reviews Immunology, Vol. 3, no. 11, pp. 867-878, 2003.
31. M. Sixt, N. Kanazawa, M. Selg et al., "The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node," Immunity, Vol. 22, no. 1, pp. 19-29, 2005.
32. M. Zhu, Y. Yang, Y. Wang, Z. Wang, and Y. X. Fu, "LIGHT regulates inflamed draining lymph node hypertrophy," Journal of Immunology, Vol. 186, no. 12, pp. 7156-7163, 2011.
33. + cells and then by T and B cells," Journal of Immunology, Vol. 187, no. 11, pp. 5558-5567, 2011.
34. C.-Y. Yang, T. K. Vogt, S. Favre et al., "Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes," Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, no. 1, pp. E109-E118, 2014.
35. I. McConnell, J. Hopkins, and P. Lachmann, "Lymphocytetrafic through lymph nodes during cell shutdown," Ciba Foundation Symposium, Vol. 71, pp. 167-195, 1980.
36. A. Manzo, R. Caporali, B. Vitolo et al., "Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography," Rheumatology (Oxford, England), Vol. 50, no. 8, pp. 1395-1400, 2011.
37. J. B. Hay and B. B. Hobbs, "The flow of blood to lymph nodes and its relation to lymphocyte trafic and the immune response," Journal of Experimental Medicine, Vol. 145, no. 1, pp. 31-44, 1977.
38. M. T. Drayson, M. E. Smith, and L. Ford, "The sequence of changes in blood flow and lymphocyte influx to stimulated rat lymph nodes," Immunology, Vol. 44, no. 1, pp. 125-133, 1981.
39. K. A. Soderberg, G. W. Payne, A. Sato, R. Medzhitov, S. S. Segal, and A. Iwasaki, "Innate control of adaptive immunity via remodeling of lymnh node feed arteriole," Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, no. 45, pp. 16315-16320, 2005.
40. P. G. Herman, I. Yamamoto, and H. Z. Mellins, "Blood microcirculation in the lymph node during the primary immune response," Journal of Experimental Medicine, Vol. 136, no. 4, pp. 697-714, 1972.
41. N. D. Anderson, A. O. Anderson, and R. G. Wyllie, "Microvascular changes in lymph nodes draining skin allografts," The American Journal of Pathology, Vol. 81, no. 1, pp. 131-153, 1975.
42. B. Webster, E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu, "Regulation of lymph node vascular growth by dendritic cells," Journal of Experimental Medicine, Vol. 203, no. 8, pp. 1903-1913, 2006.
43. S. Chyou, E. H. Ekland, A. C. Carpenter et al., "Fibroblast-type reticular stromal cells regulate the lymph node vasculature," Journal of Immunology, Vol. 181, no. 6, pp. 3887-3896, 2008.
44. V. Angeli, F. Ginhoux, J. Llodrà et al., "B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization," Immunity, Vol. 24, no. 2, pp. 203-215, 2006.
45. T. C. Tzeng, S. Chyou, S. Tian et al., "CD11c(hi) dendritic cells regulate the re-establishment of vascular quiescence and stabilization after immune stimulation of lymph nodes," Journal of Immunology, Vol. 184, no. 8, pp. 4247-4257, 2010.
46. V. Mumprecht, F. Roudnicky, and M. Detmar, "Inflammation-induced lymph node lymphangiogenesis is reversible," The American Journal of Pathology, Vol. 180, no. 3, pp. 874-879, 2012.
47. L. Mandik-Nayak, B. T. Wipke, F. F. Shih, E. R. Unanue, and P. M. Allen, "Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node," Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, no. 22, pp. 14368-14373, 2002.
48. S. T. Proulx, E. Kwok, Z. You et al., "Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography," Arthritis and Rheumatology, Vol. 56, no. 12, pp. 4024-4037, 2007.
49. S. T. Proulx, E. Kwok, Z. You et al., "MRI and quantification of draining lymph node function in inflammatory arthritis," Annals of the New York Academy of Sciences, Vol. 1117, pp. 106-123, 2007.
50. E. M. Bouta, Y. Ju, H. Rahimi et al., "Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis," PLoS ONE, Vol. 8, no. 9, Article ID e73766, 2013.
51. J. Li, I. Kuzin, S. Moshkani et al., "Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy," Journal of Immunology, Vol. 184, no. 11, pp. 6142-6150, 2010.
52. R. Guo, Q. Zhou, S. T. Proulx et al., "Inhibition of lymphan-giogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis," Arthritis and Rheumatism, Vol. 60, no. 9, pp. 2666-2676, 2009.
53. Q. Zhou, R. Guo, R. Wood et al., "Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice," Arthritis and Rheumatism, Vol. 63, no. 8, pp. 2318-2328, 2011.
54. S. Bugatti, B. Vitolo, R. Caporali, C. Montecucco, and A. Manzo, "B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers," BioMed Research International, Vol. 2014, Article ID 681678, 14 pages, 2014.
55. J. Li, Q. Zhou, R. W. Wood et al., "CD23(+)/CD21(hi) B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice," Arthritis Research and Therapy, Vol. 13, no. 4, article R138, 2011.
56. J. Li, Y. Ju, E. M. Bouta et al., "Eficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow," Arthritis & Rheumatism, Vol. 65, no. 1, pp. 130-138, 2013.
57. A. Young and G. Koduri, "Extra-articular manifestations and complications of rheumatoid arthritis," Best Practice & Research: Clinical Rheumatology, Vol. 21, no. 5, pp. 907-927, 2007.
58. M. D. Robertson, F. D. Hart, W. F. White, G. Nuki, and P. L. Boardman, "Rheumatoid lymphadenopathy," Annals of the Rheumatic Diseases, Vol. 27, no. 3, pp. 253-260, 1968.
59. A. Fleming, S. Dodman, J. M. Crown, and M. Corbett, "Extra articular features in early rheumatoid disease," British Medical Journal, Vol. 1, no. 6020, pp. 1241-1243, 1976.
60. M. A. Cimmino, C. Salvarani, P. Macchioni et al., "Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis," Rheumatology International, Vol. 19, no. 6, pp. 213-217, 2000.
61. J. S. Nosanchuk and B. Schnitzer, "Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study," Cancer, Vol. 24, no. 2, pp. 243-254, 1969.
62. C. A. Kelly, A. J. Malcolm, and I. Griffiths, "Lymphadenopathy in rheumatic patients," Annals of the Rheumatic Diseases, Vol. 46, no. 3, pp. 224-227, 1987.
63. G. M. Kondratowicz, D. P. M. Symmons, P. A. Bacon, R. A. K. Mageed, and E. L. Jones, "Rheumatoid lymphadenopathy: a morphological and immunohistochemical study," Journal of Clinical Pathology, Vol. 43, no. 2, pp. 106-113, 1990.
64. R. F. Willkens, G. F. Roth, G. Husby, and R. C. Williams Jr., "Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma," Annals of the Rheumatic Diseases, Vol. 39, no. 2, pp. 147-151, 1980.
65. M. Kojima, T. Motoori, and S. Nakamura, "Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients," Biomedicine and Pharmacotherapy, Vol. 60, no. 10, pp. 663-672, 2006.
66. R. C. Mellors, R. Heimer, J. Corcos, and L. Korngold, "Cellular origin of rheumatoid factor," Journal of Experimental Medicine, Vol. 110, no. 6, pp. 875-886, 1959.
67. Y. Imai, T. Sato, M. Yamakawa, T. Kasajima, A. Suda, and Y. Watanabe, "A morphological and immunohistochemical study of lymphoid germinal centers in synovial and lymph node tissues from rheumatoid arthritis patients with special reference to complement components and their receptors," Acta Pathologica Japonica, Vol. 39, no. 2, pp. 127-134, 1989.
68. M. H. De Hair, I. A. J. Zijlstra, M. J. H. Boumans et al., "Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool," Annals of the Rheumatic Diseases, Vol. 71, no. 11, pp. 1911-1912, 2012.
69. L. G. M. van Baarsen, M. J. H. de Hair, T. H. Ramwadhdoebe et al., "The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 8, pp. 1420-1424, 2013.
70. L. G. M. Van Baarsen, W. H. Bos, F. Rustenburg et al., "Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis," Arthritis and Rheumatism, Vol. 62, no. 3, pp. 694-704, 2010.
71. M. Çalgüneri, M. A. Oztürk, Z. Ozbalkan, and et al., "Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus," Journal of International Medical Research, Vol. 31, no. 4, pp. 345-349, 2003.
72. D. W. Seldin, I. Habib, and G. Soudry, "Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis," Clinical Nuclear Medicine, Vol. 32, no. 7, pp. 524-526, 2007.
73. P. O. Kara, B. Kaya, G. K. Gedik, and O. Sari, "Epitrochlear and axillary lymph node visualization on FDG-PET/CT imaging in a patient with rheumatoid arthritis," Revista Espanola de Medicina Nuclear, Vol. 30, no. 3, pp. 168-170, 2011.
74. S. Basu and Y. Shejul, "Regional Lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement," Rheumatology International, Vol. 34, no. 3, pp. 413-415, 2014.
75. Y.-M. Huh, S. Kim, J.-S. Suh, H.-T. Song, K. Song, and K.H. Shin, "The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D-FSPGR MR imaging: relationship of the inflamed synovial volume," Korean Journal of Radiology, Vol. 6, no. 2, pp. 117-124, 2005.
76. W. L. Olszewski, J. Pazdur, E. Kubasiewicz, M. Zaleska, C. J. Cooke, and N. E. Miller, "Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes," Arthritis and Rheumatology, Vol. 44, no. 3, pp. 541-549, 2001.
77. M. Ying, K. S. S. Bhatia, Y. P. Lee, H. Y. Yuen, and A. T. Ahuja, "Review of ultrasonography of malignant neck nodes: greyscale, doppler, contrast enhancement and elastography," Cancer Imaging, Vol. 13, no. 4, pp. 658-669, 2014.
78. L. Klareskog, J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson, "Immunity to citrullinated proteins in rheumatoid arthritis," Annual Review of Immunology, Vol. 26, pp. 651-675, 2008.
79. U. Harre, D. Georgess, H. Bang et al., "Induction of osteo-clastogenesis and bone loss by human autoantibodies against citrullinated vimentin," Journal of Clinical Investigation, Vol. 122, no. 5, pp. 1791-1802, 2012.
80. K. Amara, J. Steen, F. Murray et al., "Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition," Journal of Experimental Medicine, Vol. 210, no. 3, pp. 445-455, 2013.
81. F. Humby, M. Bombardieri, A. Manzo et al., "Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium," PLoS Medicine, Vol. 6, no. 1, article e1, 2009.
82. S. Bugatti, A. Manzo, B. Vitolo et al., "High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease," Rheumatology, Vol. 53, no. 10, pp. 1886-1895, 2014.
83. S. Bugatti, A. Manzo, F. Benaglio et al., "Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs," Arthritis Research and Therapy, Vol. 14, no. 1, article R34, 2012.
84. S. Bugatti, R. Caporali, A. Manzo, B. Vitolo, C. Pitzalis, and C. Montecucco, "Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment," Arthritis & Rheumatism, Vol. 52, no. 11, pp. 3448-3459, 2005.
85. J. Rangel-Moreno, L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall, "Inducible bronchus-associated lymphoid tissue (iBALT) in patients withpulmonary complications of rheumatoid arthritis," Journal of Clinical Investigation, Vol. 116, no. 12, pp. 3183-3194, 2006.
86. J. M. Gardner, J. J. DeVoss, R. S. Friedman et al., "Deletional tolerance mediated by extrathymic aire-expressing cells," Science, Vol. 321, no. 5890, pp. 843-847, 2008.
87. A. L. Fletcher, V. Lukacs-Kornek, E. D. Reynoso et al., "Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions," The Journal of Experimental Medicine, Vol. 207, no. 4, pp. 689-697, 2010.
88. J. N. Cohen, C. J. Guidi, E. F. Tewalt et al., "Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation," The Journal of Experimental Medicine, Vol. 207, no. 4, pp. 681-688, 2010.
89. + cells," Immunity, Vol. 39, no. 3, pp. 560-572, 2013.
90. P. Höglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis, "Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes," Journal of Experimental Medicine, Vol. 189, no. 2, pp. 331-339, 1999.
91. M. C. Gagnerault, J. J. Luan, C. Lotton, and F. Lepault, "Pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice," Journal of Experimental Medicine, Vol. 196, no. 3, pp. 369-377, 2002.
92. H. Kim, R. P. Kataru, and G. Y. Koh, "Inflammation-associated lymphangiogenesis: a double-edged sword?" The Journal of Clinical Investigation, Vol. 124, no. 3, pp. 936-942, 2014.
93. L. C. Dieterich, C. D. Seidel, and M. Detmar, "Lymphatic vessels: new targets for the treatment of inflammatory diseases," Angiogenesis, Vol. 17, no. 2, pp. 359-371, 2014.
94. K. W. Tan, S. Z. Chong, and V. Angeli, "Inflammatory lymphangiogenesis: cellular mediators and functional implications," Angiogenesis, Vol. 17, no. 2, pp. 373-381, 2014.
95. P. Baluk, T. Tammela, E. Ator et al., "Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation," The Journal of Clinical Investigation, Vol. 115, no. 2, pp. 247-257, 2005.
96. R. Huggenberger, S. Ullmann, S. T. Proulx, B. Pytowski, K. Alitalo, and M. Detmar, "Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation," Journal of Experimental Medicine, Vol. 207, no. 10, pp. 2255-2269, 2010.
97. R. Huggenberger, S. S. Siddiqui, D. Brander et al., "An important role of lymphatic vessel activation in limiting acute inflammation," Blood, Vol. 117, no. 17, pp. 4667-4678, 2011.
98. C. A. Hitchon and H. S. El-Gabalawy, "The synovium in rheumatoid arthritis," Open Rheumatology Journal, Vol. 5, no. 1, pp. 107-114, 2011.
99. A. Manzo, M. Bombardieri, F. Humby, and C. Pitzalis, "Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling," Immunological Reviews, Vol. 233, no. 1, pp. 267-285, 2010.
100. G. Schett and E. Gravallese, "Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment," Nature Reviews Rheumatology, Vol. 8, no. 11, pp. 656-664, 2012.
101. C. Pitzalis, S. Kelly, and F. Humby, "New learnings on the patho-physiology of RA from synovial biopsies," Current Opinion in Rheumatology, Vol. 25, no. 3, pp. 334-344, 2013.
102. S. Bugatti, A. Manzo, M. Bombardieri et al., "Synovial tissue heterogeneity and peripheral blood biomarkers," Current Rheumatology Reports, Vol. 13, no. 5, pp. 440-448, 2011.
103. S. Bugatti, A. Manzo, R. Caporali, and C. Montecucco, "Assessment of synovitis to predict bone erosions in rheumatoid arthritis," Therapeutic Advances in Musculoskeletal Disease, Vol. 4, no. 4, pp. 235-244, 2012.
104. S. Rantapää-Dahlqvist, B. A. W. de Jong, E. Berglin et al., "Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis," Arthritis and Rheumatism, Vol. 48, no. 10, pp. 2741-2749, 2003.
105. M. M. J. Nielen, D. van Schaardenburg, H. W. Reesink et al., "Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors," Arthritis and Rheumatism, Vol. 50, no. 2, pp. 380-386, 2004.
106. M. G. H. van de Sande, M. J. H. de Hair, C. van der Leij et al., "Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase," Annals of the Rheumatic Diseases, Vol. 70, no. 5, pp. 772-777, 2011.
107. Y. Y. J. Gent, A. E. Voskuyl, R. W. Kloet et al., "Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study," Arthritis and Rheumatism, Vol. 64, no. 1, pp. 62-66, 2012.
108. A. Krabben, W. Stomp, D. M. F. M. van der Heijde et al., "MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 9, pp. 1540-1544, 2013.
109. M. J. H. de Hair, M. G. H. van de Sande, T. H. Ramwadhdoebe et al., "Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis," Arthritis and Rheumatology, Vol. 66, no. 3, pp. 513-522, 2014.
110. G. Reynisdottir, R. Karimi, V. Joshua et al., "Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis," Arthritis and Rheumatology, Vol. 66, no. 1, pp. 31-39, 2014.
111. J. U. Scher, C. Ubeda, M. Equinda et al., "Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis," Arthritis and Rheumatism, Vol. 64, no. 10, pp. 3083-3094, 2012.
112. T. R. Mikuls, G. M. Thiele, K. D. Deane et al., "Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis," Arthritis and Rheumatism, Vol. 64, no. 11, pp. 3522-3530, 2012.
113. S. B. Brusca, S. B. Abramson, and J. U. Scher, "Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity," Current Opinion in Rheumatology, Vol. 26, no. 1, pp. 101-107, 2014.
114. S. Bugatti, R. Caporali, A. Manzo, G. Sakellariou, S. Rossi, and C. Montecucco, "Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis," Annals of the Rheumatic Diseases, Vol. 71, no. 4, pp. 625-626, 2012.
115. A. Krabben, W. Stomp, D. M. F. M. van der Heijde et al., "MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 9, pp. 1540-1544, 2013.
116. F. M. McQueen, "Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective," Arthritis Research and Therapy, Vol. 14, no. 5, article 224, 2012.
117. S. Bugatti, A. Manzo, R. Caporali, and C. Montecucco, "Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective," Arthritis Research and Therapy, Vol. 14, no. 6, p. 229, 2012.
118. C. L. Willard-Mack, "Normal structure, function, and histology of lymph nodes," Toxicologic Pathology, Vol. 34, no. 5, pp. 409-424, 2006.
119. U. H. von Andrian and T. R. Mempel, "Homing and cellular trafic in lymph nodes," Nature Reviews Immunology, Vol. 3, no. 11, pp. 867-878, 2003.
120. M. Sixt, N. Kanazawa, M. Selg et al., "The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node," Immunity, Vol. 22, no. 1, pp. 19-29, 2005.
121. M. Zhu, Y. Yang, Y. Wang, Z. Wang, and Y. X. Fu, "LIGHT regulates inflamed draining lymph node hypertrophy," Journal of Immunology, Vol. 186, no. 12, pp. 7156-7163, 2011.
122. + cells and then by T and B cells," Journal of Immunology, Vol. 187, no. 11, pp. 5558-5567, 2011.
123. C.-Y. Yang, T. K. Vogt, S. Favre et al., "Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes," Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, no. 1, pp. E109-E118, 2014.
124. I. McConnell, J. Hopkins, and P. Lachmann, "Lymphocytetrafic through lymph nodes during cell shutdown," Ciba Foundation Symposium, Vol. 71, pp. 167-195, 1980.
125. A. Manzo, R. Caporali, B. Vitolo et al., "Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography," Rheumatology (Oxford, England), Vol. 50, no. 8, pp. 1395-1400, 2011.
126. J. B. Hay and B. B. Hobbs, "The flow of blood to lymph nodes and its relation to lymphocyte trafic and the immune response," Journal of Experimental Medicine, Vol. 145, no. 1, pp. 31-44, 1977.
127. M. T. Drayson, M. E. Smith, and L. Ford, "The sequence of changes in blood flow and lymphocyte influx to stimulated rat lymph nodes," Immunology, Vol. 44, no. 1, pp. 125-133, 1981.
128. K. A. Soderberg, G. W. Payne, A. Sato, R. Medzhitov, S. S. Segal, and A. Iwasaki, "Innate control of adaptive immunity via remodeling of lymnh node feed arteriole," Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, no. 45, pp. 16315-16320, 2005.
129. P. G. Herman, I. Yamamoto, and H. Z. Mellins, "Blood microcirculation in the lymph node during the primary immune response," Journal of Experimental Medicine, Vol. 136, no. 4, pp. 697-714, 1972.
130. N. D. Anderson, A. O. Anderson, and R. G. Wyllie, "Microvascular changes in lymph nodes draining skin allografts," The American Journal of Pathology, Vol. 81, no. 1, pp. 131-153, 1975.
131. B. Webster, E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu, "Regulation of lymph node vascular growth by dendritic cells," Journal of Experimental Medicine, Vol. 203, no. 8, pp. 1903-1913, 2006.
132. S. Chyou, E. H. Ekland, A. C. Carpenter et al., "Fibroblast-type reticular stromal cells regulate the lymph node vasculature," Journal of Immunology, Vol. 181, no. 6, pp. 3887-3896, 2008.
133. V. Angeli, F. Ginhoux, J. Llodrà et al., "B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization," Immunity, Vol. 24, no. 2, pp. 203-215, 2006.
134. T. C. Tzeng, S. Chyou, S. Tian et al., "CD11c(hi) dendritic cells regulate the re-establishment of vascular quiescence and stabilization after immune stimulation of lymph nodes," Journal of Immunology, Vol. 184, no. 8, pp. 4247-4257, 2010.
135. V. Mumprecht, F. Roudnicky, and M. Detmar, "Inflammation-induced lymph node lymphangiogenesis is reversible," The American Journal of Pathology, Vol. 180, no. 3, pp. 874-879, 2012.
136. L. Mandik-Nayak, B. T. Wipke, F. F. Shih, E. R. Unanue, and P. M. Allen, "Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node," Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, no. 22, pp. 14368-14373, 2002.
137. S. T. Proulx, E. Kwok, Z. You et al., "Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography," Arthritis and Rheumatology, Vol. 56, no. 12, pp. 4024-4037, 2007.
138. S. T. Proulx, E. Kwok, Z. You et al., "MRI and quantification of draining lymph node function in inflammatory arthritis," Annals of the New York Academy of Sciences, Vol. 1117, pp. 106-123, 2007.
139. E. M. Bouta, Y. Ju, H. Rahimi et al., "Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis," PLoS ONE, Vol. 8, no. 9, Article ID e73766, 2013.
140. J. Li, I. Kuzin, S. Moshkani et al., "Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy," Journal of Immunology, Vol. 184, no. 11, pp. 6142-6150, 2010.
141. R. Guo, Q. Zhou, S. T. Proulx et al., "Inhibition of lymphan-giogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis," Arthritis and Rheumatism, Vol. 60, no. 9, pp. 2666-2676, 2009.
142. Q. Zhou, R. Guo, R. Wood et al., "Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice," Arthritis and Rheumatism, Vol. 63, no. 8, pp. 2318-2328, 2011.
143. S. Bugatti, B. Vitolo, R. Caporali, C. Montecucco, and A. Manzo, "B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers," BioMed Research International, Vol. 2014, Article ID 681678, 14 pages, 2014.
144. J. Li, Q. Zhou, R. W. Wood et al., "CD23(+)/CD21(hi) B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice," Arthritis Research and Therapy, Vol. 13, no. 4, article R138, 2011.
145. J. Li, Y. Ju, E. M. Bouta et al., "Eficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow," Arthritis & Rheumatism, Vol. 65, no. 1, pp. 130-138, 2013.
146. A. Young and G. Koduri, "Extra-articular manifestations and complications of rheumatoid arthritis," Best Practice & Research: Clinical Rheumatology, Vol. 21, no. 5, pp. 907-927, 2007.
147. M. D. Robertson, F. D. Hart, W. F. White, G. Nuki, and P. L. Boardman, "Rheumatoid lymphadenopathy," Annals of the Rheumatic Diseases, Vol. 27, no. 3, pp. 253-260, 1968.
148. A. Fleming, S. Dodman, J. M. Crown, and M. Corbett, "Extra articular features in early rheumatoid disease," British Medical Journal, Vol. 1, no. 6020, pp. 1241-1243, 1976.
149. M. A. Cimmino, C. Salvarani, P. Macchioni et al., "Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis," Rheumatology International, Vol. 19, no. 6, pp. 213-217, 2000.
150. J. S. Nosanchuk and B. Schnitzer, "Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study," Cancer, Vol. 24, no. 2, pp. 243-254, 1969.
151. C. A. Kelly, A. J. Malcolm, and I. Griffiths, "Lymphadenopathy in rheumatic patients," Annals of the Rheumatic Diseases, Vol. 46, no. 3, pp. 224-227, 1987.
152. G. M. Kondratowicz, D. P. M. Symmons, P. A. Bacon, R. A. K. Mageed, and E. L. Jones, "Rheumatoid lymphadenopathy: a morphological and immunohistochemical study," Journal of Clinical Pathology, Vol. 43, no. 2, pp. 106-113, 1990.
153. R. F. Willkens, G. F. Roth, G. Husby, and R. C. Williams Jr., "Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma," Annals of the Rheumatic Diseases, Vol. 39, no. 2, pp. 147-151, 1980.
154. M. Kojima, T. Motoori, and S. Nakamura, "Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients," Biomedicine and Pharmacotherapy, Vol. 60, no. 10, pp. 663-672, 2006.
155. R. C. Mellors, R. Heimer, J. Corcos, and L. Korngold, "Cellular origin of rheumatoid factor," Journal of Experimental Medicine, Vol. 110, no. 6, pp. 875-886, 1959.
156. Y. Imai, T. Sato, M. Yamakawa, T. Kasajima, A. Suda, and Y. Watanabe, "A morphological and immunohistochemical study of lymphoid germinal centers in synovial and lymph node tissues from rheumatoid arthritis patients with special reference to complement components and their receptors," Acta Pathologica Japonica, Vol. 39, no. 2, pp. 127-134, 1989.
157. M. H. De Hair, I. A. J. Zijlstra, M. J. H. Boumans et al., "Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool," Annals of the Rheumatic Diseases, Vol. 71, no. 11, pp. 1911-1912, 2012.
158. L. G. M. van Baarsen, M. J. H. de Hair, T. H. Ramwadhdoebe et al., "The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis," Annals of the Rheumatic Diseases, Vol. 72, no. 8, pp. 1420-1424, 2013.
159. L. G. M. Van Baarsen, W. H. Bos, F. Rustenburg et al., "Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis," Arthritis and Rheumatism, Vol. 62, no. 3, pp. 694-704, 2010.
160. M. Çalgüneri, M. A. Oztürk, Z. Ozbalkan, and et al., "Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus," Journal of International Medical Research, Vol. 31, no. 4, pp. 345-349, 2003.
161. D. W. Seldin, I. Habib, and G. Soudry, "Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis," Clinical Nuclear Medicine, Vol. 32, no. 7, pp. 524-526, 2007.
162. P. O. Kara, B. Kaya, G. K. Gedik, and O. Sari, "Epitrochlear and axillary lymph node visualization on FDG-PET/CT imaging in a patient with rheumatoid arthritis," Revista Espanola de Medicina Nuclear, Vol. 30, no. 3, pp. 168-170, 2011.
163. S. Basu and Y. Shejul, "Regional Lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement," Rheumatology International, Vol. 34, no. 3, pp. 413-415, 2014.
164. Y.-M. Huh, S. Kim, J.-S. Suh, H.-T. Song, K. Song, and K.H. Shin, "The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D-FSPGR MR imaging: relationship of the inflamed synovial volume," Korean Journal of Radiology, Vol. 6, no. 2, pp. 117-124, 2005.
165. W. L. Olszewski, J. Pazdur, E. Kubasiewicz, M. Zaleska, C. J. Cooke, and N. E. Miller, "Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes," Arthritis and Rheumatology, Vol. 44, no. 3, pp. 541-549, 2001.
166. M. Ying, K. S. S. Bhatia, Y. P. Lee, H. Y. Yuen, and A. T. Ahuja, "Review of ultrasonography of malignant neck nodes: greyscale, doppler, contrast enhancement and elastography," Cancer Imaging, Vol. 13, no. 4, pp. 658-669, 2014.
167. L. Klareskog, J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson, "Immunity to citrullinated proteins in rheumatoid arthritis," Annual Review of Immunology, Vol. 26, pp. 651-675, 2008.
168. U. Harre, D. Georgess, H. Bang et al., "Induction of osteo-clastogenesis and bone loss by human autoantibodies against citrullinated vimentin," Journal of Clinical Investigation, Vol. 122, no. 5, pp. 1791-1802, 2012.
169. K. Amara, J. Steen, F. Murray et al., "Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition," Journal of Experimental Medicine, Vol. 210, no. 3, pp. 445-455, 2013.
170. F. Humby, M. Bombardieri, A. Manzo et al., "Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium," PLoS Medicine, Vol. 6, no. 1, article e1, 2009.
171. S. Bugatti, A. Manzo, B. Vitolo et al., "High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease," Rheumatology, Vol. 53, no. 10, pp. 1886-1895, 2014.
172. S. Bugatti, A. Manzo, F. Benaglio et al., "Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs," Arthritis Research and Therapy, Vol. 14, no. 1, article R34, 2012.
173. S. Bugatti, R. Caporali, A. Manzo, B. Vitolo, C. Pitzalis, and C. Montecucco, "Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment," Arthritis & Rheumatism, Vol. 52, no. 11, pp. 3448-3459, 2005.
174. J. Rangel-Moreno, L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall, "Inducible bronchus-associated lymphoid tissue (iBALT) in patients withpulmonary complications of rheumatoid arthritis," Journal of Clinical Investigation, Vol. 116, no. 12, pp. 3183-3194, 2006.
175. J. M. Gardner, J. J. DeVoss, R. S. Friedman et al., "Deletional tolerance mediated by extrathymic aire-expressing cells," Science, Vol. 321, no. 5890, pp. 843-847, 2008.
176. A. L. Fletcher, V. Lukacs-Kornek, E. D. Reynoso et al., "Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions," The Journal of Experimental Medicine, Vol. 207, no. 4, pp. 689-697, 2010.
177. J. N. Cohen, C. J. Guidi, E. F. Tewalt et al., "Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation," The Journal of Experimental Medicine, Vol. 207, no. 4, pp. 681-688, 2010.
178. + cells," Immunity, Vol. 39, no. 3, pp. 560-572, 2013.